Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. develops medical technology for spine surgery, with a business centered on procedural spine solutions, surgical instrumentation, imaging, navigation and informatics. Company updates commonly address surgical revenue trends, EOS revenue, surgeon adoption, product launches such as Valence and EOS Insight, and the continued development of its InformatiX platform through subsidiaries including Alphatec Spine, EOS imaging and SafeOp Surgical.
Recurring developments also include financing actions, credit-facility activity, strategic partnerships tied to spinal fusion and regenerative technology, profitability metrics and annual outlook updates. Governance items, including board composition changes, appear alongside operating results and capital-structure announcements.
Alphatec Holdings (NASDAQ: ATEC) reported preliminary financial results for Q3 2022, projecting total revenues between $89 million and $90 million, reflecting a growth of 42% to 43% year-over-year. Organic revenue is expected to rise by 51% to 53%, fueled by procedural volume growth exceeding 30%. The company has adjusted its full-year 2022 revenue guidance to approximately 40% growth, up from 34%. ATEC ends the quarter with about $106 million in cash.
Alphatec Holdings (NASDAQ: ATEC) announced its participation in the North American Spine Society (NASS) 37th Annual Meeting from October 12-15, 2022. The company will showcase its innovative spine surgery solutions, emphasizing advancements in lateral access surgery, including the Prone TransPsoas (PTP™) approach. Key presentations include topics on clinical distinction and the use of EOS imaging. The event aims to demonstrate how ATEC enhances clinical predictability and reproducibility in spine surgery. CEO Pat Miles expressed enthusiasm for their progress and future innovations.
Alphatec Holdings, Inc. (Nasdaq: ATEC) announced participation in three upcoming investor events. CFO Todd Koning and VP of Finance Robert Judd will engage in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022, at 5:00 p.m. ET. They will also participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:05 p.m. ET, and the Lake Street Big 6 Conference on September 14, 2022. Webcasts will be available in the Investor Relations Section of the Company’s website.
Alphatec Holdings, Inc. (ATEC) reported a 35% increase in total revenue to $84 million for Q2 2022, with organic growth of 30%. The GAAP gross margin was 66%, and the company reported an operating loss of $36 million. Notably, EOS imaging contributed $12 million in revenue, a 49% growth. ATEC raised its full-year revenue guidance to $325 million, reflecting an anticipated 34% growth. The firm hosted over 150 surgeons, increasing users by 23%, alongside a 10% increase in average revenue per surgery.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will participate in several investor events, featuring CEO Pat Miles and CFO Todd Koning. Key events include the 42nd Annual Canaccord Genuity Growth Conference on August 10, 2022, and the 7th Annual Needham Virtual MedTech and Diagnostics 1x1 Conference on August 15, 2022. Additionally, they will join the Piper Sandler MedTech and Diagnostics West Coast Bus Tour and the RBC West Coast Medical Device Bus Tour, both on August 23, 2022. Webcasts of these events will be available in the Investor Relations Section of ATEC's website.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will report its second quarter 2022 financial results on August 4, 2022, after market close. A live webcast for this event will occur at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties can access the webcast through the Investor Relations Section of ATEC's website. Call-in details for participation will also be provided before the event.
Alphatec Holdings Inc. (Nasdaq: ATEC) is hosting an Investor Day at its headquarters in Carlsbad, CA, today from 8:15 a.m. to 12:00 p.m. PT. The event will showcase ATEC's commitment to transforming spine surgery and present the company’s financial outlook. A live webcast will be available on the Investor Relations section of ATEC's website, with a replay accessible post-event. ATEC aims to revolutionize spine surgery through innovative solutions and is dedicated to establishing itself as the standard bearer in the field.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announces participation in key investor events. CFO Todd Koning will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at 11:30 am PDT. Additionally, CEO Pat Miles and CFO Koning will attend the Goldman Sachs 43rd Annual Global Healthcare Conference on June 13, 2022, at Terranea Resort in Rancho Palos Verdes, CA. ATEC focuses on innovative spine surgery solutions, driven by its Organic Innovation Machine, aiming to set a new standard in spine surgery.
Alphatec Holdings (ATEC) reported 61% revenue growth for Q1 2022, with total revenue reaching $71 million. Organic growth stood at 39%. The company generated over $10 million in EOS imaging revenue, contributing to an improved full-year guidance of $316 million, reflecting a 30% increase year-over-year. Operating expenses were noted at $90 million, leading to a GAAP operating loss of $41 million. ATEC emphasizes its focus on innovative technologies to enhance surgical outcomes and is poised for continued growth, showcasing an optimistic outlook for the future.
Alphatec Holdings, Inc. (NASDAQ: ATEC) will report its first quarter 2022 financial results on May 5, 2022, after market close. A live webcast will take place at 1:30 p.m. PT / 4:30 p.m. ET. The event can be accessed via the Investor Relations Section of ATEC’s website.
Replays will be available for twelve months, with dial-in options for two hours post-webcast until May 12, 2022.